Biocan Novel DHPPi, Lyophilisate and solvent for suspension for injection
Biocan Novel DHPPi, Lyophilisate and solvent for suspension for injection
Pooblaščeno
- Canine distemper virus, strain CDV Bio 11/A, Live
- Canine adenovirus 2, strain CAV-2-Bio 13, Live
- Canine parvovirus 2b, strain CPV-2b Bio 12/B, Live
- Canine parainfluenza virus 2, strain CPiV-2-Bio 15, Live
Identifikacija zdravila
Ime zdravila:
Biocan Novel DHPPi, Lyophilisate and solvent for suspension for injection
Biocan Novel DHPPi vakcina A.U.V.
Pot uporabe:
-
Subkutana uporaba
Podatki o zdravilu
Učinkovina / Jakost:
-
Na voljo samo v English5.10log10 tissue culture infective dose 501.00Dose
-
Na voljo samo v English5.30log10 tissue culture infective dose 501.00Dose
-
Na voljo samo v English6.60log10 tissue culture infective dose 501.00Dose
-
Na voljo samo v English5.10log10 tissue culture infective dose 501.00Dose
Farmacevtska oblika:
-
Liofilizat in vehikel za suspenzijo za injiciranje
Withdrawal period by route of administration:
-
Subkutana uporaba
- Dog
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
- QI07AD04
Pravni status za dobavo / izdajo zdravila:
-
Zdravilo, ki se izdaja na veterinarski recept
Status dovoljenja:
-
Valid
Dodatne informacije
Imetnik dovoljenja za promet z zdravilom:
- Bioveta a.s.
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
- Bioveta a.s.
Pristojni organ:
- National Food Chain Safety Office
Številka dovoljenja :
- 3564/X/14 NÉBIH ÁTI
Datum spremembe statusa dovoljenja:
Številka postopka:
- CZ/V/0124/001
Zadevne države članice:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Kako koristna je bila ta stran?: